Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should every patient with left-ventricular systolic dysfunction receive implantable cardioverter-defibrillators?

Nature Clinical Practice Cardiovascular Medicine volume 2, pages 188–189 (2005)Cite this article

boxed-textNanthakumar K et al. (2004) Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 44: 2166–2172

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bardy G et al. (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352: 225–237

    Article  CAS  Google Scholar 

  2. Kadish A et al. (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350: 2151–2158

    Article  CAS  Google Scholar 

  3. Moss AJ et al. (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335: 1933–1940

    Article  CAS  Google Scholar 

  4. The Centers for Medicare & Medicaid Services (CMS) [http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=148]

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. the Chester and Deborah Cooley Professor of Medicine and a scholar of the Feinberg Cardiovascular Institute, Chicago, IL, USA

    Alan Kadish

Authors
  1. Alan Kadish
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan Kadish.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kadish, A. Should every patient with left-ventricular systolic dysfunction receive implantable cardioverter-defibrillators?. Nat Rev Cardiol 2, 188–189 (2005). https://doi.org/10.1038/ncpcardio0155

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0155

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing